Connect Biopharma Holdings Limited (CNTB)
NGM – Real Time Price. Currency in USD
2.12
+0.02 (0.95%)
At close: Jun 12, 2026, 4:00 PM EDT
2.16
+0.04 (1.89%)
After-hours: Jun 12, 2026, 5:41 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
2.12
+0.02 (0.95%)
At close: Jun 12, 2026, 4:00 PM EDT
2.16
+0.04 (1.89%)
After-hours: Jun 12, 2026, 5:41 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $46.0M significantly exceed its total debt $693.0K, ensuring strong financial flexibility
Total current assets $55.0M exceed Total current liabilities $17.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$16.0M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.23 | 6.05 | 10 | |
| Quick ratio | 3.23 | 5.63 | 10 | |
| Debt to Equity | 0.02 | 0.30 | 9.0 | |
| Debt to Assets | 0.01 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | 26M | 64K | 233K |
| Gross Profit | -1M | -720K | 25M | N/A | -176K |
| Operating Income | -118M | -69M | -22M | -58M | -66M |
| Net Income | -118M | -62M | -16M | -55M | -65M |
| EBITDA | -117M | -68M | -22M | -57M | -66M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -36.48 | 1.0 |
| Next quarter | N/A | 14.64 | 4.5 |
| Current year | 8225.02 | -7.18 | 5.5 |
| Next year | 77 | 0.27 | 6.0 |
| Weighted average score | 4.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -28.38 | -26.17 | -37.74 | 3.3 |
| Y/Y | 999 | -88.83 | -77.33 | -59.4 | 3.3 |
| 3y average | 632.75 | -44.2 | -43.67 | -2.76 | 3.3 |
| 5y average | 779.25 | -34.09 | -16.65 | -54.18 | 3.3 |
| Weighted average score | 3.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |